Tempest Therapeutics, Inc. (TPST) Gross profit 2016–2017
Tempest Therapeutics, Inc. (TPST) annual gross profit history from SEC filings — each fiscal year as reported.
-$495,000FY2017 · since FY2016: -$4.7M → -$495,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | -$495,000 | +89.6% |
| FY2016 | -$4.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TPST financial trends
TPST RevenueTPST Net incomeTPST Net marginTPST Gross marginTPST Operating incomeTPST Operating marginTPST Operating cash flowTPST Free cash flowTPST Capital expendituresTPST Return on equityTPST Stock buybacksTPST Dividends paidTPST Total assetsTPST Total liabilitiesTPST Shareholders’ equityTPST overview →